| Variables . | Patients (n = 103) . |
|---|---|
| Age (years) | 65.4 (9.8) |
| Older than 70 years of age | 34 (33%) |
| Sex, male | 57 (55%) |
| BMI (kg/m2) | 26.0 (4.4) |
| FEV1% | 84.0 (26.0) |
| FEV1 < 70% | 20 (19%) |
| DLCO% | 72.8 (17.3) |
| PS > 1 | 15 (15%) |
| CAD | 14 (14%) |
| CVD | 13 (13%) |
| CKD | 7 (6.8%) |
| Diabetes | 9 (8.7%) |
| VATS | 87 (84%) |
| Pneumonectomy | 3 (2.9%) |
| LOS | 4.9 (2.8) |
| Number of patients by country | |
| UK | 30 |
| Switzerland | 20 |
| Italy | 32 |
| Canada | 6 |
| Spain | 15 |
| Types of complications (n = 16) | |
| Pneumonia | 2 |
| PAL | 9 |
| AF | 2 |
| Haemothorax | 1 |
| Atelectasis | 1 |
| Respiratory failure | 1 |
| Variables . | Patients (n = 103) . |
|---|---|
| Age (years) | 65.4 (9.8) |
| Older than 70 years of age | 34 (33%) |
| Sex, male | 57 (55%) |
| BMI (kg/m2) | 26.0 (4.4) |
| FEV1% | 84.0 (26.0) |
| FEV1 < 70% | 20 (19%) |
| DLCO% | 72.8 (17.3) |
| PS > 1 | 15 (15%) |
| CAD | 14 (14%) |
| CVD | 13 (13%) |
| CKD | 7 (6.8%) |
| Diabetes | 9 (8.7%) |
| VATS | 87 (84%) |
| Pneumonectomy | 3 (2.9%) |
| LOS | 4.9 (2.8) |
| Number of patients by country | |
| UK | 30 |
| Switzerland | 20 |
| Italy | 32 |
| Canada | 6 |
| Spain | 15 |
| Types of complications (n = 16) | |
| Pneumonia | 2 |
| PAL | 9 |
| AF | 2 |
| Haemothorax | 1 |
| Atelectasis | 1 |
| Respiratory failure | 1 |
Results are expressed as means and standard deviations for numeric variables or count and percentage of total for categorical variables.
AF: atrial fibrillation requiring medical cardioversion; atelectasis requiring bronchoscopy; respiratory failure requiring mechanical ventilation > 24 h; BMI: body mass index; CAD: coronary artery disease; CKD: chronic kidney disease; CVD: cerebrovascular disease; DLCO: carbon monoxide lung diffusion capacity; FEV1: forced expiratory volume in 1 s; LOS: length of stay; PAL: prolonged air leak (air leak > 5 days); PS: Eastern Cooperative Oncology Group performance status; VATS: video-assisted thoracoscopic surgery.
| Variables . | Patients (n = 103) . |
|---|---|
| Age (years) | 65.4 (9.8) |
| Older than 70 years of age | 34 (33%) |
| Sex, male | 57 (55%) |
| BMI (kg/m2) | 26.0 (4.4) |
| FEV1% | 84.0 (26.0) |
| FEV1 < 70% | 20 (19%) |
| DLCO% | 72.8 (17.3) |
| PS > 1 | 15 (15%) |
| CAD | 14 (14%) |
| CVD | 13 (13%) |
| CKD | 7 (6.8%) |
| Diabetes | 9 (8.7%) |
| VATS | 87 (84%) |
| Pneumonectomy | 3 (2.9%) |
| LOS | 4.9 (2.8) |
| Number of patients by country | |
| UK | 30 |
| Switzerland | 20 |
| Italy | 32 |
| Canada | 6 |
| Spain | 15 |
| Types of complications (n = 16) | |
| Pneumonia | 2 |
| PAL | 9 |
| AF | 2 |
| Haemothorax | 1 |
| Atelectasis | 1 |
| Respiratory failure | 1 |
| Variables . | Patients (n = 103) . |
|---|---|
| Age (years) | 65.4 (9.8) |
| Older than 70 years of age | 34 (33%) |
| Sex, male | 57 (55%) |
| BMI (kg/m2) | 26.0 (4.4) |
| FEV1% | 84.0 (26.0) |
| FEV1 < 70% | 20 (19%) |
| DLCO% | 72.8 (17.3) |
| PS > 1 | 15 (15%) |
| CAD | 14 (14%) |
| CVD | 13 (13%) |
| CKD | 7 (6.8%) |
| Diabetes | 9 (8.7%) |
| VATS | 87 (84%) |
| Pneumonectomy | 3 (2.9%) |
| LOS | 4.9 (2.8) |
| Number of patients by country | |
| UK | 30 |
| Switzerland | 20 |
| Italy | 32 |
| Canada | 6 |
| Spain | 15 |
| Types of complications (n = 16) | |
| Pneumonia | 2 |
| PAL | 9 |
| AF | 2 |
| Haemothorax | 1 |
| Atelectasis | 1 |
| Respiratory failure | 1 |
Results are expressed as means and standard deviations for numeric variables or count and percentage of total for categorical variables.
AF: atrial fibrillation requiring medical cardioversion; atelectasis requiring bronchoscopy; respiratory failure requiring mechanical ventilation > 24 h; BMI: body mass index; CAD: coronary artery disease; CKD: chronic kidney disease; CVD: cerebrovascular disease; DLCO: carbon monoxide lung diffusion capacity; FEV1: forced expiratory volume in 1 s; LOS: length of stay; PAL: prolonged air leak (air leak > 5 days); PS: Eastern Cooperative Oncology Group performance status; VATS: video-assisted thoracoscopic surgery.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
